Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remodeling the pyramid--a concept whose time has come.

K R Wilske1, L A Healey

  • 1University of Washington, Section of Rheumatology, Virginia Mason Clinic, Seattle 98101.

The Journal of Rheumatology
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workshop summary: the role of biologicals in the treatment of patients with refractory rheumatoid arthritis.

Rheumatology (Oxford, England)·2000
Same author

VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA).

Clinical and experimental immunology·1998
Same author

What's in a name?

The Journal of rheumatology·1998
Same author

Case management study: an elderly patient with muscle pain.

Bulletin on the rheumatic diseases·1997
Same author

On fibromyalgia.

Bulletin on the rheumatic diseases·1996
Same author

Results of "satisfaction with disease control" survey.

The Journal of rheumatology·1996
Same journal

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

The Journal of rheumatology·2026
Same journal

Concurrent Calcium Pyrophosphate Deposition Disease and Gout of the Cervical Spine Presenting With Subacute Neck Pain and Radiculopathy.

The Journal of rheumatology·2026
Same journal

The Need for Weight Communication Guidelines in Pediatric Rheumatology.

The Journal of rheumatology·2026
Same journal

Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

The Journal of rheumatology·2026
Same journal

Qualitative Analysis of Physical Activity Engagement in Women with Self-Reported SLE: The Role of Symptoms, Healthcare Providers, and the Environment.

The Journal of rheumatology·2026
Same journal

Tumoral Calcinosis-like Calcification of the Proximal Interphalangeal Joint Mimicking Rheumatoid Arthritis Flare.

The Journal of rheumatology·2026
See all related articles

Traditional rheumatoid arthritis (RA) treatments often fail to prevent joint damage. A new "step-down bridge" approach using combined medications may offer better inflammation control and prevent long-term joint damage in RA patients.

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Traditional rheumatoid arthritis (RA) treatment pyramids often fail to adequately suppress inflammation, leading to persistent joint damage.
  • The concept of 'disease-modifying' drugs being distinct from anti-inflammatory agents is challenged; disease modification correlates with inflammation control, notably with prednisone.
  • Current RA therapies provide incomplete or temporary inflammation suppression through various mechanisms.

Purpose of the Study:

  • To propose a novel therapeutic strategy for RA management.
  • To investigate a "step-down bridge" concept for controlling inflammation in early RA.
  • To evaluate the efficacy and safety of combined drug therapy in RA.

Main Methods:

  • Development of a new therapeutic program based on controlling inflammation in early RA.

Related Experiment Videos

  • Implementation of a "step-down bridge" concept involving sequential medication withdrawal.
  • Comparison of toxicity profiles between combined drug therapy and individual drug use.

    • Main Results:

    • Early patient experiences suggest that combined drug therapy does not increase toxicity compared to individual drug use.
    • The proposed "step-down bridge" concept contrasts with traditional sequential drug addition methods.
    • Further time and comparative studies are required to determine optimal drug combinations and validate the step-down approach.

    Conclusions:

    • The traditional RA treatment pyramid is insufficient for preventing joint damage due to inadequate inflammation control.
    • A "step-down bridge" therapeutic program combining drugs to control early RA inflammation is proposed.
    • This novel approach aims for sustained inflammation control, improved quality of life, and prevention of joint damage, though further validation is needed.